Vaxcyte, Inc. (PCVX) DCF Valuation

Valuación de DCF Vaxcyte, Inc. (PCVX)

US | Healthcare | Biotechnology | NASDAQ
Vaxcyte, Inc. (PCVX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Vaxcyte, Inc. (PCVX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Buscas evaluar el valor intrínseco de Vaxcyte, Inc.? Nuestra calculadora DCF (PCVX) integra datos del mundo real con extensas características de personalización, lo que le permite ajustar los pronósticos y mejorar sus estrategias de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -49.0 -87.8 -98.3 -214.3 -464.9 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 1.2 1.4 1.8 9.2 3.2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -50.2 -89.2 -100.1 -223.5 -468.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 59.0 386.2 246.0 931.4 1,080.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories -.2 -.3 -1.2 -1.0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 3.4 29.8 6.8 9.8 14.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -1.2 -1.2 -6.6 -5.8 -67.9 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -53.5 -87.8 -100.1 -239.6 -468.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -49.8 -61.1 -127.0 -233.5 -529.0 -14.6 .0 .0 .0 .0
WACC, % 9.19 9.19 9.19 9.19 9.19 9.19 9.19 9.19 9.19 9.19
PV UFCF
SUM PV UFCF -13.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -13
Net Debt -368
Equity Value 355
Diluted Shares Outstanding, MM 97
Equity Value Per Share 3.65

What You Will Get

  • Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Vaxcyte, Inc. (PCVX) financial data pre-loaded to enhance your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically for you.
  • Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing efficiency.

Key Features

  • Real-Life PCVX Data: Pre-filled with Vaxcyte’s historical financials and forward-looking projections.
  • Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
  • Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
  • User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Vaxcyte, Inc. (PCVX) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Vaxcyte, Inc.'s (PCVX) intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Vaxcyte, Inc. (PCVX)?

  • Accurate Data: Up-to-date Vaxcyte financials provide trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Built-in calculations save you from starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple design and clear instructions make it accessible for all users.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and dependable valuation models for investment analysis in Vaxcyte, Inc. (PCVX).
  • Biotech Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Vaxcyte, Inc. (PCVX).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Pharmaceutical Enthusiasts: Gain insights into how biotech companies like Vaxcyte, Inc. (PCVX) are valued in the market.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring intricate valuation calculations.
  • Real-World Data: Vaxcyte, Inc.'s (PCVX) historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Visualizations and tables for clear, actionable results.

No products were found matching.